1,3,4-thiadiazole has been researched along with Granulocytic Leukemia, Chronic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ali, TFS; Altıntop, MD; Ciftci, HI; Fujita, M; Kaplancıklı, ZA; Koga, R; Otsuka, M; Özdemir, A; Radwan, MO; Sever, B | 1 |
1 other study(ies) available for 1,3,4-thiadiazole and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
Design, Synthesis, and Biological Evaluation of Novel 1,3,4-Thiadiazole Derivatives as Potential Antitumor Agents against Chronic Myelogenous Leukemia: Striking Effect of Nitrothiazole Moiety.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Fusion Proteins, bcr-abl; Humans; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Spectroscopy; Models, Molecular; Protein Binding; Spectrometry, Mass, Electrospray Ionization; Thiadiazoles | 2017 |